BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 23349832)

  • 1. MicroRNA-22 (miR-22) overexpression is neuroprotective via general anti-apoptotic effects and may also target specific Huntington's disease-related mechanisms.
    Jovicic A; Zaldivar Jolissaint JF; Moser R; Silva Santos Mde F; Luthi-Carter R
    PLoS One; 2013; 8(1):e54222. PubMed ID: 23349832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased striatal RGS2 expression is neuroprotective in Huntington's disease (HD) and exemplifies a compensatory aspect of HD-induced gene regulation.
    Seredenina T; Gokce O; Luthi-Carter R
    PLoS One; 2011; 6(7):e22231. PubMed ID: 21779398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered microRNA regulation in Huntington's disease models.
    Lee ST; Chu K; Im WS; Yoon HJ; Im JY; Park JE; Park KH; Jung KH; Lee SK; Kim M; Roh JK
    Exp Neurol; 2011 Jan; 227(1):172-9. PubMed ID: 21035445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. microRNA-128a dysregulation in transgenic Huntington's disease monkeys.
    Kocerha J; Xu Y; Prucha MS; Zhao D; Chan AW
    Mol Brain; 2014 Jun; 7():46. PubMed ID: 24929669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interrogation of brain miRNA and mRNA expression profiles reveals a molecular regulatory network that is perturbed by mutant huntingtin.
    Jin J; Cheng Y; Zhang Y; Wood W; Peng Q; Hutchison E; Mattson MP; Becker KG; Duan W
    J Neurochem; 2012 Nov; 123(4):477-90. PubMed ID: 22906125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PRMT5- mediated symmetric arginine dimethylation is attenuated by mutant huntingtin and is impaired in Huntington's disease (HD).
    Ratovitski T; Arbez N; Stewart JC; Chighladze E; Ross CA
    Cell Cycle; 2015; 14(11):1716-29. PubMed ID: 25927346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-365 functions as a mechanosensitive microRNA to inhibit end plate chondrocyte degeneration by targeting histone deacetylase 4.
    Zheng Q; Li XX; Xiao L; Shao S; Jiang H; Zhang XL; Sun LY; Xu HG
    Bone; 2019 Nov; 128():115052. PubMed ID: 31472300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of the repressor complex REST-mSIN3b by small molecules restores neuronal gene transcription in Huntington's disease models.
    Conforti P; Zuccato C; Gaudenzi G; Ieraci A; Camnasio S; Buckley NJ; Mutti C; Cotelli F; Contini A; Cattaneo E
    J Neurochem; 2013 Oct; 127(1):22-35. PubMed ID: 23800350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysregulation of gene expression in primary neuron models of Huntington's disease shows that polyglutamine-related effects on the striatal transcriptome may not be dependent on brain circuitry.
    Runne H; Régulier E; Kuhn A; Zala D; Gokce O; Perrin V; Sick B; Aebischer P; Déglon N; Luthi-Carter R
    J Neurosci; 2008 Sep; 28(39):9723-31. PubMed ID: 18815258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The bifunctional microRNA miR-9/miR-9* regulates REST and CoREST and is downregulated in Huntington's disease.
    Packer AN; Xing Y; Harper SQ; Jones L; Davidson BL
    J Neurosci; 2008 Dec; 28(53):14341-6. PubMed ID: 19118166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of mitochondrial morphology and cell cycle by microRNA-214 targeting Mitofusin2.
    Bucha S; Mukhopadhyay D; Bhattacharyya NP
    Biochem Biophys Res Commun; 2015 Oct; 465(4):797-802. PubMed ID: 26307536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Full sequence of mutant huntingtin 3'-untranslated region and modulation of its gene regulatory activity by endogenous microRNA.
    Kim KH; Abu Elneel K; Shin JW; Keum JW; Seong D; Kwak S; Lee R; Gusella JF; MacDonald ME; Seong IS; Lee JM
    J Hum Genet; 2019 Oct; 64(10):995-1004. PubMed ID: 31296921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transducer of regulated CREB-binding proteins (TORCs) transcription and function is impaired in Huntington's disease.
    Chaturvedi RK; Hennessey T; Johri A; Tiwari SK; Mishra D; Agarwal S; Kim YS; Beal MF
    Hum Mol Genet; 2012 Aug; 21(15):3474-88. PubMed ID: 22589249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene dysregulation in Huntington's disease: REST, microRNAs and beyond.
    Johnson R; Buckley NJ
    Neuromolecular Med; 2009; 11(3):183-99. PubMed ID: 19458943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNAs located in the Hox gene clusters are implicated in huntington's disease pathogenesis.
    Hoss AG; Kartha VK; Dong X; Latourelle JC; Dumitriu A; Hadzi TC; Macdonald ME; Gusella JF; Akbarian S; Chen JF; Weng Z; Myers RH
    PLoS Genet; 2014 Feb; 10(2):e1004188. PubMed ID: 24586208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Micro RNA -214,-150,-146a and-125b target Huntingtin gene.
    Sinha M; Ghose J; Bhattarcharyya NP
    RNA Biol; 2011; 8(6):1005-21. PubMed ID: 22048026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotective role of Sirt1 in mammalian models of Huntington's disease through activation of multiple Sirt1 targets.
    Jiang M; Wang J; Fu J; Du L; Jeong H; West T; Xiang L; Peng Q; Hou Z; Cai H; Seredenina T; Arbez N; Zhu S; Sommers K; Qian J; Zhang J; Mori S; Yang XW; Tamashiro KL; Aja S; Moran TH; Luthi-Carter R; Martin B; Maudsley S; Mattson MP; Cichewicz RH; Ross CA; Holtzman DM; Krainc D; Duan W
    Nat Med; 2011 Dec; 18(1):153-8. PubMed ID: 22179319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Astrocytes from cortex and striatum show differential responses to mitochondrial toxin and BDNF: implications for protection of striatal neurons expressing mutant huntingtin.
    Saba J; López Couselo F; Turati J; Carniglia L; Durand D; de Laurentiis A; Lasaga M; Caruso C
    J Neuroinflammation; 2020 Oct; 17(1):290. PubMed ID: 33023623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysregulation of REST-regulated coding and non-coding RNAs in a cellular model of Huntington's disease.
    Soldati C; Bithell A; Johnston C; Wong KY; Stanton LW; Buckley NJ
    J Neurochem; 2013 Feb; 124(3):418-30. PubMed ID: 23145961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MAP kinase phosphatase 1 (MKP-1/DUSP1) is neuroprotective in Huntington's disease via additive effects of JNK and p38 inhibition.
    Taylor DM; Moser R; Régulier E; Breuillaud L; Dixon M; Beesen AA; Elliston L; Silva Santos Mde F; Kim J; Jones L; Goldstein DR; Ferrante RJ; Luthi-Carter R
    J Neurosci; 2013 Feb; 33(6):2313-25. PubMed ID: 23392662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.